Lupus & antiphospholipid syndrome

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay andCrithidia luciliaeassay in a multiethnic racial cohort of patients with SLE

Lupus Sci MedPublished Cohort study

Authors' conclusion

Our data demonstrate that discordance of positivity between both assays for anti-dsDNA is relatively common, occurring in a fifth of patients overall and a third of visits. EIA positivity is associated with LN less often than CLIFT positivity.

Study context

Population
Patients with SLE fulfilling ACR, SLICC and/or ACR/EULAR classification criteria, in a well-phenotyped multiethnic/racial cohort586 paired results
Participants
207 patients
Exposure
Anti-dsDNA by multiplex enzyme immunoassay (EIA) vs Crithidia luciliae immunofluorescence test (CLIFT)
Outcome
Concordance or discordance of paired anti-dsDNA results by EIA and CLIFT
Methodological detailsmultiethnic/racial cohort, paired simultaneous testing
  • Multiethnic/racial cohort
  • Paired simultaneous testing

Main finding

As reported in the abstract

Concordance of paired anti-dsDNA results

Concordant pairs

377

Discordant pairs

209

Patients always with discordant paired results (of 207)

41

Patients always with titre discordance

39

Observational data: associations, not effects.

Further findings

Positivity in patients with LN (n=100)

Sensitivity for LN

Specificity for LN

Flare prediction (42 patients with flare assessment within 90 days of paired result)

Mild flares with concordant positive results
6 of 7
Severe flares with concordant positive results
all four

Original publication

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay andCrithidia luciliaeassay in a multiethnic racial cohort of patients with SLE. Lupus Sci Med. Published 14 November 2023. doi:10.1136/lupus-2023-001012

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.